We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New specific guidance on dose-dependent prolongation of QTc with ondansetron.
(Eli Lilly Nederland B.V.) Remaining stocks of affected batch should be quarantined and returned to original supplier for credit – class 2 action within 48 hours. (EL (13)A/22)
Quinine has dose-dependent QT-interval-prolonging effects and should be used with caution in patients with risk factors for QT prolongation or in those with atrioventricular block.
This letter gives additional guidance on the issue of prisoners requiring a prolonged hospital stay.
Toremifene (fareston) is associated with a dose-dependent risk of QT prolongation.
Upper Tribunal Administrative Appeals Chamber decision by Judge Hemingway on 6 April 2016.
The Secretary of State for Health and Social Care addressed the All-Party Parliamentary Group for Longevity at the launch of their longer, healthier lives strategy.
Upper Tribunal Administrative Appeals Chamber decision by Judge Brunner on 12 January 2017.
Upper Tribunal Administrative Appeals Chamber decision by Judge Hemingway on 27 December 2018.
Employment Tribunal decision.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).